New shot for lupus enters first human tests

NCT ID NCT07323173

Recruiting now Disease control Sponsor: Nanjing Leads Biolabs Co.,Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a single injection of a new drug, LBL-047, in healthy adults and people with mild-to-moderate systemic lupus erythematosus (SLE). The main goal is to check safety and side effects. About 112 participants will receive either the drug or a placebo. This research helps determine if LBL-047 is safe enough for larger studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC LUPUS ERYTHEMATOSUS

Contacts and locations

Locations

Mianyang Central Hospital
NOT_YET_RECRUITING

Mianyang, Sichuan, 621051, China
Nanjing Drum Tower Hospital
NOT_YET_RECRUITING

Nanjing, Jiangsu, 210008, China
Pingxiang People's Hospital
NOT_YET_RECRUITING

Pingxiang, Jiangxi, 337099, China
Shanghai JiaoTong University School of Medicine，Renji Hospital
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, 200001, China
Shanghai Public Health Clinical Center
RECRUITING

Shanghai, Shanghai Municipality, 200083, China
Shanxi Bethune Hospital
NOT_YET_RECRUITING

Taiyuan, Shanxi, 030032, China
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
NOT_YET_RECRUITING

Guangzhou, Guangdong, 510120, China
The First Affiliated Hospital of Bengbu Medical University
NOT_YET_RECRUITING

Bengbu, Anhui, 233004, China
The Second Affiliated Hospital of Xian Jiaotong University
NOT_YET_RECRUITING

Xian, Shanxi, 710004, China
West China Hospital of Sichuan University
NOT_YET_RECRUITING

Chengdu, Sichuan, 610041, China
Xiangya School of Medicine of Central South University
NOT_YET_RECRUITING

Changsha, Hunan, 410028, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.